Journal of Bioequivalence & Bioavailability

Strategies and innovation in biosimilar drug development, achievement and challenges ? An Indian perspective

International Conference and Exhibition on Biowaivers & Biosimilars

September 10-12, 2012 Hilton San Antonio Airport, USA

Villoo Morawala-Patell

Accepted Abstracts: J Bioequiv Availab

Abstract:

Hatim Motiwala is a postgraduate in Microbiology and at completion stage of Ph.D. from The M.S. University of Baroda, India. He has 12 years of experience working on biosimilars. His core expertise is in mammalian cell culture with working experience in cell line development, mammalian upstream process development, in-vitro bioassays, technology evaluation and transfer. Currently, working at a post of Senior Scientist and managing three biosimilar monoclonal antibody development programs at Intas Biopharmaceutical Limited. Earlier he was associated with Biocon Biopharmaceuticals, Cadila Pharmaceuticals, Sun Pharma Advanced Research Centre, and Chiron Vaccines Limited (Aventis).

Biography :

Villoo Morawala-Patell is the Founder, Chairperson & Managing Director of Avesthagen Limited. She has obtained a bachelor in science from Osmania University, Hyderabad, a master in science from Bombay University, Mumbai and a doctor of philosophy in plant molecular biology from the University of Louis Pasteur, Strasbourg, France. She is a key member of the Task Force and Vision Group for Biotechnology, instituted by the Government of Karnataka and a founding member of the Association for Biotechnology Led Enterprises. Dr. Villoo has also received the Karamveer Puraskar from the Indian Confederation of Non-Governmental Organisations for her contribution in the field of agriculture and healthcare and the Adolfo Ibanez University Award for her achievements in innovation.